Home/Filings/4/0001209191-23-043274
4//SEC Filing

Sandercock Colin 4

Accession 0001209191-23-043274

CIK 0001645460other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 12:27 PM ET

Size

5.3 KB

Accession

0001209191-23-043274

Insider Transaction Report

Form 4
Period: 2023-07-21
Sandercock Colin
SVP, GENERAL COUNSEL
Transactions
  • Award

    Stock Option (right to buy)

    2023-07-21+75,00075,000 total
    Exercise: $4.20Exp: 2033-07-20Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023.

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001724870

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 12:27 PM ET
Size
5.3 KB